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Caesarean section in an awake patient is undoubtedly a major test of regional 
anaesthesia. The surgery is major, profound blockade of many spinal segments required, 
strong visceral stimulation present, sudden cardiovascular changes are compounded by 
posture and fetal well-being may be influenced by several physiologic variables and 
drugs.
Spinal anaesthesia is perhaps the most efficient and elegant approach 
to this challenge. With a small needle and an almost homeopathic amount of 
drug, profound anaesthesia and excellent operating conditions can be readily 
provided for this major intrabdominal surgery.
Spinal hypotension, the most clinically significant aspect of spinal anaesthesia can 
occur rapidly and may have a significant impact on the neonatal outcome. Recently, there 
has been an interest in using analgesic additives to subarachnoid local anaesthetics to 
decrease the local anaesthetic dose so as to reduce the incidence and degree of 
hypotension but at the same time without compromising intra operative analgesia and also 
to enable faster recovery and providing efficient post operative analgesia.
Opioids were the first clinically used selective spinal analgesics after 
the  discovery  of  opioid  receptors  in  the  spinal  cord.  Lipophilic  opioids 
(fentanyl and sufentanil) are increasingly being administered intrathecally as 
adjuvants  to  local  anaesthetics1.  They  have  been  shown  to  enhance  the 
quality  of   local  anaesthetic  induced  subarachnoid  block  and  to  provide 
postoperative  analgesia  and  also,  they  reduce  the  hypotension  due  to 
subarachnoid  block  by  reducing  the  dose  of  the  local  anaesthetics  and 
decrease the ephedrine requirements to combat  hypotension.
In  our  study,  we  compare  the  efficacy  of  the  combination  of 
intrathecal 25 µg fentanyl and 5mg of hyperbaric bupivacaine 0.5% with that 
of  7.5mg  hyperbaric  bupivacaine  0.5% alone  regarding  the  incidence  of 
hypotension and ephedrine requirements in lower segment Caesarean section 
during surgery and early post operative period. 
AIM OF THE STUDY
           To evaluate the efficacy of the combination of intrathecal fentanyl 25 
µg and 5mg of 0.5% hyperbaric bupivacaine in comparison with 7.5mg of 
0.5% hyperbaric bupivacaine used alone for lower segment caesarean section 
with respect to 
- Time of onset of analgesia and motor blockade 
- Duration of sensory and motor block
- Quality  of  introperative  anaesthesia  and  period  of  effective 
analgesia
- Incidence of hypotension 
-  Ephedrine requirements to combat hypotension    
To evaluate the side effects and complications that may arise with the 
use of intrathecal fentanyl as an adjuvant
SPINAL ANAESTHESIA
Spinal  (subarachnoid/intrathecal)  anaesthesia  is  a  form  of  central 
neuraxial block in which, a temporary interruption of nerve transmission is 
achieved following injection of  local  anaesthetic  and/or  adjuvant solution 
into the subarachnoid space. Spinal anaesthesia is one of the most frequently 
employed methods of regional anesthesia.
Anatomy 
The vertebral canal extends from the foramen magnum to the sacral 
hiatus.    It is formed by the dorsal spines, pedicles and laminae of successive 
vertebrae 
(7  cervical,  12  thoracic,  5  lumbar  and  5  sacral).  The  vertebrae  are  held 
together  by  a  series  of  overlapping  ligaments  namely,  the  anterior  and 
posterior longitudinal ligaments, ligamentum flavum, interspinous ligament, 
supraspinous ligament and the intervertebral discs.
The spinal cord, a direct continuation of the medulla oblongata begins 
at  the  upper  border  of  the  atlas  and  terminates  distally  in  the  conus 
medullaris. The distal termination, because of the differential growth rates 
between the bony vertebral canal and central nervous  system varies from L3 
in the infant, to the lower border of LI in the adult. 
Surrounding the spinal cord in the bony vertebral column are three membranes 
( from within to the periphery); the pia mater,  arachnoid mater and  dura mater. The pia 
mater is a highly vascular membrane that closely invests the spinal cord. The arachnoid 
mater is a delicate nonvascular membrane closely attached  to the outermost dura mater. 
Between the two innermost membranes is the subarachnoid space. In this space are the 
cerebrospinal fluid (CSF), spinal nerves, blood vessels that supply the spinal cord and the 
dentate ligaments. Although the spinal cord ends at the lower border of LI in adults, the 
subarachnoid space continues to S2. The outermost membrane in the spinal canal is the 
longitudinally organized fibroelastic membrane,  the dura mater. This layer is the direct 
extension of the cranial dura mater and extends as the spinal dura mater from the foramen 
magnum to S2,  where the filum terminale (an extension of the of the pia mater beginning 
at the conus medullaris) blends with the periosteum of the coccyx. There is a potential 
space between the dura mater and arachnoid, the subdural space which contains only 
small amounts of serous fluid to allow the dura and arachnoid move over each other. 
Surrounding  the dura mater is the epidural space which extends form the foramen 
magnum to the sacral hiatus. Posterior to the epidural space is the ligamentum flavum 
which extends from the foramen magnum to the sacral hiatus. Immediately posterior to 
the ligamentum flavum is the interspinous ligament. Extending from the external occipital 
protuberence to the coccyx, posterior to these structures is the supraspinous ligament.
Lumbar puncture is routinely done below the L2 vertebra down to the 
L5-S1 interspace to avoid damaging the spinal cord which ends at the lower 
border of L1 vertebra in adults.
Cerebrospinal Fluid
The cerebrospinal fluid (CSF) in an ultrafiltrate of blood plasma with 
which it is in hydrostatic and osmotic equilibrium. It is a clear, colourless 
fluid found in the spinal and cranial subarachnoid space and in the ventricles 
of the brain.  The average volume in the adult  ranges from 120-150ml of 
which 35ml is in the ventricles, 25ml is in the cerebral subarachnoid space 
and 75ml is in the spinal subarachnoid space. It is secreted by the choroid 
plexus at a rate of 0.3-0.4ml/ minute and is absorbed into the venous sinuses 
through the arachnoid villi.
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The cerebrospinal fluid plays an important role in spinal anaesthesia as 
media for dispersion of the local anesthetic drug to the spinal nerve roots. An 
important factor determining the spread of drugs in the subarachnoid space is 
the specific gravity of the injected solution compared with that of CSF.
 Mechanism of Spinal Anaesthesia
Injection of local anaesthetics into the spinal CSF allows access to sites of action 
both within the spinal cord and the peripheral nerve roots. The nerve roots leaving the 
spinal canal are not covered by epineurium and are readily exposed to the local 
anaesthetics within the CSF. Therefore afferent impulses entering the central nervous 
system via the dorsal nerve roots and efferent impulses leaving via the ventral nerve roots 
are blocked during spinal anaesthesia. Spinal local anaesthetics block sodium channels 
and electrical conduction in spinal nerve roots. There are also multiple potential action of 
local anaesthetics within the spinal cord at different sites. Local anaesthetics can exert 
sodium channel block within the dorsal and ventral horns, inhibiting generation and 
propogation of electrical activity3. The order in which the nerve fibres are blocked are 
preganglionic sympathetic B fibres followed by temperature fibres (cold before warmth), 
fibres carrying pin- prick sensation, touch, deep pressure, somatic motor sensation and 
lastly fibres conveying vibration sense and proprioceptive impulses. Sympathetic fibres 
are blocked 2-3 segments higher than sensory level. Sensory fibres are blocked 2 
segments higher than motor fibres. Recovery is roughly in the reverse order.
Physiologic effects of spinal anaesthesia
Cardiovascular effects 
Sympathetic blockade leads to dilatation of resistance and capacitance vessels 
below the level of blockade. The diminished cardiac output consequent to diminished 
venous return decreases the blood pressure - hence spinal hypotension occurs.  Other 
factors contributing to spinal hypotension are: 
- Dilatation  of  post  arteriolar  capillaries  and  small  venules  due  to 
blockade of vasoconstrictors. 
- Blockade of sympathetic supply to heart – T1-T4 
-  Blockade  of  sympathetic  supply  to  adrenals  with  consequent 
catecholamine depletion  
- Compression of great vessels within the abdomen by gravid uterus 
Compensatory vasoconstriction in the upper part of the body can help to 
maintain the blood pressure. The effect of posture promoting venous return 
will mimise hypotension. During spinal anaesthesia, both Marey’s law and 
Bainbridge reflex operate, but the latter predominates.
Respiratory system 
Correctly placed and conducted spinal anaesthesia should not depress 
respiration.  Even with high thoracic levels, tidal volume is unchanged. A 
small decrease in vital capacity occurs because of loss of contribution from 
abdominal muscles in forced expiration. Phrenic nerve block may not occur 
even with total spinal anesthesia .
 
Metabolic and hormonal effects 
Spinal anaesthesia can minimise or prevent the rise in blood sugar, 
cortisol and catecholamine response to surgery. 
Gastrointestinal effects 
There is contracted bowel with relaxed sphincters, increased peristalsis 
and increased intraluminal pressure.
Factors affecting height of blockade
The major factors affecting the height of blockade are 
1) Baricity of the drug 
2) Dosage (mass) of drug 
3) Volume and concentration of the drug 
4) Position of the patient 
5) Site of injection 
6) Volume and pressure of CSF
Fate of Local Anaesthetics in subarachnoid Space 
Following injection local anaesthetic solution into subarachnoid space,  its 
concentration falls rapidly. The initial steep fall is due to mixing with CSF and 
subsequent absorption into nerve roots and spinal cord. The egress of local anaesthetics 
following subarachnoid injection is primarily by vascular absorption with no hydrolysis 
or degradation taking place in the CSF4. Depending on the type of drug used, it is 
metabolized in plasma by pseudocholinesterase or in the liver.
Indications for Subarachnoid  block 
Spinal anaesthesia can be administered whenever a surgical procedure can be done 
with a sensory level of anaesthesia that does not produce adverse patient outcome, mostly 
below T6. Such procedures include lower abdominal surgeries, lower limb surgeries, 
urological procedures, obstetric procedures, gynaecological surgeries and perineal & 
rectal surgeries.
Contraindications for Subarachnoid block 
An absolute contraindication for subarachnoid block is patient refusal.
Other contraindications are;
• Local sepsis 
• Uncorrected coagulopathy 
• Uncontrolled blood loss/ shock
• Fixed cardiac output states, severe cardiac disease
• Documented allergy to local anaesthetics 
• Raised intracranial pressure 
• Neurological disease
• Major spine deformities/ previous surgery on the spine 
Complications of Subarachnoid Block
Immediate
1. Hypotension  
Physiological effects
2. Bradycardia 
3. Toxicity due to intravascular injection
4. Allergic reaction to local anaesthetic
5. Hypoventilation in patients with higher thoracic levels.
Late 
1. Post dural puncture headache
2. Retention of urine
3. Backache
4. Meningitis
5. Transient lesions of cauda equina
6. Sixth nerve palsy




Opiate receptors were first identified in the central nervous system in 
1973 by Pert CB and Snyder SH5. Subsequently, large populations of these 
receptors  were  localized  in  the  dorsal  horn  of  the  spinal  cord4.  In  1976, 
Yaksh TL and Rudy TA performed animal  studies  and demonstrated  the 
ability  of  intrathecal  opioids  to  produce  analgesia6.  In  1979,  Wang  and 
colleagues reported pain relief using intrathecal morphine in cancer patients 
and in the same year, Behar et al. achieved the same result injecting the drug 
into the epidural space7,8.
 
Spinal Opioid Receptors-Location
Opioid  receptors  are  synthesized  in  the  cell  body  of  the  sensory 
neuron and are transported in both the central and peripheral directions. In 
the spinal cord, opioid receptors are found in the dorsal horn in the terminal 
zones of C fibers primarily in lamina II of the substantia gelatinosa9. Spinal 
opioid receptors are 70% µ 24%  δ and 6% κ.
Mechanism of Action
Spinal  opioids  act  at  nerve  synapses  either  presynaptically  (as 
neuromodulators) or postsynaptically (as neurotransmitters)10. Stimulation of 
presynaptic receptors is associated with hyperpolarisation of the terminal and 
reduced substance P release11. This relates primarily to inhibition of voltage-
gated calcium channels.  Postsynaptic membranes contain opioid receptors 
linked  to  potassium  channels.  Stimulation  of  these  receptors  enhances 
outward flow of potassium, thereby stabilizing the membrane, making it less 
sensitive  to  neurotransmitters12.   These  actions  are  carried  out  by  second 
messengers (G proteins).
With the injection of an opioid into the CSF, a reservoir of drug is created that 
passively diffuses into the dorsal horn of the spinal cord where it exerts its action by 
binding to opioid receptors.
Pharmacokinetics
The onset of analgesic effect following intrathecal administration of an 
opioid is directly proportional to the lipid solubility of the drug, whereas the 
duration  of  effect  is  longer  with  more  hydrophilic  compounds.  Opioids 
placed in  the  epidural  space  undergo significant  systemic  absorption  and 
passage into the subarachnoid space.  Vascular  absorption after intrathecal 
administration of opioids is insignificant. Cephalad movement of opioids in 
the CSF is dependent on lipid solubility. Lipid soluble opioids like fentanyl 
are limited in the cephalad migration by uptake into the spinal cord, while 
hydrophilic opioids like morphine remain in the CSF for transfer to more 
cephalad locations. 
Loss of analgesia after intraspinal injection primarily results from clearance of 
drug from the site of action. Intrathecal opioids are eliminated by diffusion along the 
neuraxis and vascular absorption. It is not yet established what role metabolism plays in 
the termination of action of intrathecal opioids. 
Tolerance
Decrease  in  effect  over  time  to  a  given  dose  of  drugs  has  been 
demonstrated with intrathecal opioids. There is good evidence in support of 
the glutamate receptor of the NMDA type to be involved in the mechanism 
of tolerance.
Benefits
• Long lasting post operative analgesia after a single injection
• Precise and reliable placement of low concentration of drug near 
its site of action13
The principle disadvantage is its lack of titrability and the need to either repeat the 
injection or consider other options when the analgesic effect of the initial dose wanes. 
Nevertheless, it is common clinical experience that after the analgesic effect of the initial 
intrathecal dose wanes, the intensity of post operative pain is greatly diminished and can 
be satisfactorily managed by other modalities.
Side Effects14,15  
The side effects of neuraxial opioids are due to the presence of drug in the 
cerebrospinal fluid and/or systemic circulation. Typically most side effects are dose 
dependent.
The common side effects are 1. respiratory depression, 2. pruritus, 3. nausea and 
vomiting, 4. urinary retention and  5. sedation.
Respiratory Depression
The real incidence of respiratory depression is not known. Early respiratory 
depression is thought to be secondary to the effect of systemically absorbed drug and 
occurs in the first two hours after intrathecal opioid injection. Delayed respiratory 
depression is likely the consequence of rostral spread of opioid in the CSF, the target site 
being the respiratory center in the floor of the fourth ventricle. The risk of delayed 
respiratory depression appears to peak at six to twelve hours after beginning therapy. 
Factors that increase the risk of delayed respiratory depression are
• High opioid doses
• Concomitant administration of parenteral opioids and other sedatives
• Hydrophilic opioid use
• Advanced age
Pulse oximetry reliably detects opioid induced arterial hypoxemia and 
supplemental oxygen is an effective treatment. A slow breath rate (<8/min) may 
accompany respiratory depression. Perhaps, the most reliable clinical sign of respiratory 
depression is a depression of level of consciousness, possibly caused by hypercarbia. 
Naloxone is effective in reversing opioid induced respiratory depression.
Pruritus
It is a common and distressing symptom seen in many patients. It may 
be  generalized  or  localized,  with  the  face  being  the  most  common  site. 
Although probably not due to histamine release, antihistamines often provide 
symptomatic  relief.  Nalbuphine  and  Naloxone  are  also  effective.  The 
mechanism by which pruritis occurs is not known with certainty.
Nausea and vomiting 
This is  due to  rostral  spread of  opioid in  the CSF to the vomiting 
center and chemoreceptor trigger zone in the floor of the fourth ventricle. 
Relief is possible with antiemetic use.
Urinary Retention 
The incidence of urinary retention is quite significant. Naloxone may 
help prevent or reverse urinary retention, but doses approaching those that 
antagonize analgesia may be needed.
Sedation
Sedation caused by intrathecal opioids is attributed to the spread of 
drug  in  CSF  receptors  in  the  thalamus,  limbic  system  or  cortex. 
Pharmacologic treatment is seldom indicated. Respiratory depression must 
be  suspected  whenever  sedation  occurs  following  intrathecal  opioid 
administration.
Myoclonus has been reported occasionally in patients receiving high 
does of intrathecal opioids 
Neurotoxicity 
Animal and human studies have not demonstrated neurotoxicity with 
any  of  the  commercially  available  preservative  free  opioid   agents 
administered by the subarachnoid route16.
Opioid- Local anaesthetic mixtures 
Adding a local anaesthetic to spinal opioids result in synergistic interaction. The 
rationale for combining intrathecal opioids and local anaesthetic is to use lower doses of 
each agent, to preserve effective analgesia and to reduce the side effect and problems 
associated with use of individual drugs17. Nociceptive pathways are interrupted at 
different sites with the two drugs. The opioid in the mixture acts by inhibiting the release 
of substance P in the dorsal horn of the spinal cord while the local anesthetic blocks 
transmission of impulses at the level of nerve axonal membrane. These two distinctive 
action may contribute to the synergy of analgesic effects that have been demonstrated.
PHARMACOLOGY OF BUPIVACAINE
Bupivacaine  is  an  amide  local  anaesthetic,  synthesized  by 
A.F.Ekenstam in 1957 and brought into clinical use in 1963.
It is produced for clinical use as a racemic mixture, containing equal 
proportion of the ‘S’ and ‘R’ enantiomers. It is supplied for clinical use as a 
hydrochloride salt.
Physico- chemical profile





Octanol/ water partition coefficient high
Lipid solubility 28
Plasma protein binding 95%
Mechanism of Action
Bupivacaine  exerts  its  effect  by  inhibition  of  sodium  channels.  It 
blocks  conduction  in  the  nerves  by  decreasing  or  preventing  the  large 
transient increase in permeability of the cell membrane to sodium ions that 
follows  depolarization  of  the  membrane.  Bupivacaine  also  reduces  the 
permeability of the resting nerve membrane to potassium as well as sodium 
ions18.
Pharmacodynamics 
Bupivacaine by virtue of its pharmacological effect, has a stabilizing 
action on all excitable membranes. In the central nervous system, stimulation 
can occur producing restlessness,  tremors and convulsions in overdosage. 
Bupivacaine also causes a reduction of automaticity in the  heart.
The clinical profile of nerve blockade produced by bupivacaine differs 
from that of lignocaine. It is 4 times more potent than lignocaine, but the 
onset of action is slower. The duration of action is considerably longer. The 
sensory block produced by bupivacaine tends to be more marked than the 
motor block.
Pharmacokinetics 
Bupivacaine is rapidly absorbed from the site of injection. The rate of rise in 
plasma bupivacaine concentration and the peak plasma concentration obtained depend on 
the route of administration. There is also some inter-individual variation and peak 
systemic concentration may occur between 5and 30 minutes after administration. The 
addition of a vasoconstrictor delays absorption and result in lower plasma concentration 
of bupivacaine.
Pharmacokinetic Profile19 
Volume of distribution at steady state (VDss) 72 litres
Clearance 0.471/min
t ½ α 2.7 min
t ½ β 28 min
t ½ γ 3.5 hrs
Metabolism
Possible  pathways  for  metabolism of  bupivacaine  include  aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and conjugation. Only the 
N-dealkylated  metabolite  N-desmethylbupivacaine  has  been  measured  in 
blood and urine after epidural and spinal administration. The degradation of 
bupivacaine takes place in the liver. Renal disease is unlikely to alter the 
kinetics of bupivacaine to any great extent.  Less than 10% of the drug is 
excreted unchanged in urine20.
The onset of action of bupivacaine occurs 20-30 minutes after a peripheral nerve 
block and duration lasts for 8-9 hours.
Clinical Applications
• Infiltration anaesthesia
• Peripheral nerve blocks
• Central neuraxial blocks (intrathecal, epidural and caudal)
Contraindications
• Paracervical block (in obstetrics)
• Known hypersensitivity to amide local anaesthetics
• Intravenous regional anaesthesia (IVRA)
Preparations Available
0.25%,0.5% solutions in 10ml and 20ml vials.
5mg/ml (0.5%) bupivacaine and 80 mg dextrose in 4ml ampoules for 
intrathecal injection 
Recommended Safe Dose
Concentration used Max. permitted dose
0.125%-0.5% 2mg/kg body wt
0.75% (not to be used in obstetric 
epidurals)
Max. over 4hrs      – 150mg
Max. during 24hrs – 400mg




Adverse reactions are associated mainly with excess plasma levels of the drug, 
which may be due to overdosage, unintentional intravascular injection or slow metabolic 
degradation.
• CNS Reactions
Excitation characterized by restlessness, anxiety, dizziness, tinnitus, blurred 
vision  or  tremors  possibly  proceeding  to  convulsions,  followed  by 
drowsiness, unconsciousness and cardiac arrest.
• Cardiovascular system effects
Part of the cardiac toxicity that occurs from high plasma concentrations of 
bupivacaine occurs because of blockade of cardiac sodium channels. Accidental 
intravenous injection of bupivacaine causes cardiac dysrhythmias,  atrioventricular block, 
ventricular tachycardia and ventricular fibrillation. Pregnancy increases the sensitivity to 
cardiotoxic effects of bupivacaine.
• Allergic reactions
Manifests  as  urticaria,  pruritus,  angioneurotic  edema  etc.  Cross 
sensitivity  among  members  of  amide  type  local  anaesthetics  has  been 
reported.
PHARMACOLOGY OF FENTANYL
Fentanyl is a synthetic phenylpiperidine opioid of the 4-anilopiperidine series 
which is structurally related to pethidine.
Commercially,  fentanyl  is  formulated  as  a  citrate,  available  as  an 





% unionized pH 7.4 8.5
Octanol / water partition coefficient 816
% bound to plasma proteins 84




This results from action of fentanyl on opioid  μ receptors both suprapinally in the 
brain and spinal cord. Intravenous fentanyl produces effective analgesia at plasma 
concentrations between 0.6-3.0 ng/ml.
• Cardiovascular System
Arterial blood pressure, cardiac output and pulmonary vascular resistance remain 
unchanged after large doses of intravenous fentanyl. Fentanyl like other opioid agonists 
(except pethidine) causes bradycardia, that responds to intravenous atropine. Peripheral 
vasodilation is much less than morphine due to absence of histamine release.
• Respiratory System
Fentanyl causes a direct dose related respiratory depression by its depressant 
effect on the medullary respiratory center, manifested as a decreased sensitivity to 
carbondioxide and reduced respiratory rate. It is reversed by intravenous Naloxone 
administration. Plasma fentanyl concentrations >2ng/ml is associated with clinical 
respiratory depression. The degree of respiratory depression is affected by various factors, 
including type of surgical population, age and individual pharmacodynamic response.
• Central nervous system
Fentanyl causes less sedation than equianalgesic doses of morphine. In 
doses of 100 μg/kg, fentanyl causes dose related reduction in cerebral blood 
flow and CMRO2.  Muscle  rigidity  probably  reflects  a  manifestation  of  a 
catatonic  state,  a  basic  pharmacologic  property  of  opioids,  related  to 
enhancement of dopamine biosynthesis in the caudate nucleus.
• Gastrointestinal Tract
Fentanyl decreases gastrointestinal tract motility, increases intrabiliary pressure 
and causes a varying incidence of nausea and vomiting. The vomiting is mediated via 
stimulation of the chemoreceptor trigger zone in the area postrema.
• Genito-urinary system
Fentanyl like other opioids causes relaxation of detrusor muscle and increase in 
urethral sphincter tone leading to urinary retention. This is probably not dose related and 
is more common with central neuraxial administration.
Pharmacokinetics
Fentanyl is a potent opioid, highly lipophilic, producing a rapid onset of action of 
relatively short duration. After intravenous administration, fentanyl is rapidly distributed 
to brain, heart and other highly perfused tissues. It also crosses the placental barrier 
easily. Peak effect occurs in 5 minutes. Within a short time, the drug redistributes to 
inactive tissue sites like skeletal muscle and fat, associated with decrease in plasma 
concentration of drug, thus terminating its effect, About 75% of initial dose undergoes 
first pass pulmonary uptake.
When low doses (1-2µg/kg) are administered, redistribution terminates 
the effect and the drug appears short acting. With administration of large 
intravenous doses or continuous infusion, progressive saturation of inactive 
tissue sites occur, with redistribution becoming insufficient to terminate drug 
action which becomes dependent on slow elimination process and the drug 
appears to be long acting.
Pharamcokinetic Profile22
Volume of distribution at steady state (VDss) 335 litres
Clearance 1530 ml/min
Effect-site equilibration time 6.8min
Hepatic extraction ratio 0.8-0.1
Context – sensitive t½ (4hrs infusion) 260 min
Elimination t½ 3.1 to 6.6 hours 
Metabolism 
Fentanyl  is  biotransformed  in  the  liver  to  inactive  metabolites, 
primarily  norfentanyl  and  several  hydroxylation  products.  Only  4-7%  of 
drug is excreted unchanged in urine. Elimination t½ of fentanyl is longer 
than  that  of  morphine  because  of  high  lipid  solubility  of  fentanyl. 
Elimination t½ is prolonged in elderly patients.  A high hepatic extraction 
ratio means that the clearance of fentanyl is limited by hepatic blood flow. 
Routes of Administration and Dosage 
• Intramuscular 
50-100µg  may  be  administered  intramuscularly  as 
premedication 30-60 minutes prior to surgery. 
• Intravenous 
Can  be  given  intraoperatively  and  for  postoperative  analgesia. 
Postoperative analgesia is achieved by intravenous loading dose of 1-2µg/kg 
followed by a continuous / variable infusion at rate of 1-2µg/kg/hr. It can be 
used for Patient – Controlled Analgesia (PCA) as a bolus dose of 20-50µg 
with lockout intervals. 
• Transdermal 
Transdermal fentanyl patch is available in four sizes, providing sustained 
release of fentanyl at rates of 25, 50, 75 and 100µg/hr for periods of 48-72 
hours. Skin acts as a secondary reservoir contributing to prolonged residual 
fentanyl concentrations. 
• Transmucosal 
Oral transmucosal fentanyl citrate (OTFC) incorporates fentanyl citrate in 
a candy mixture shaped into a lozenge or stick. The median time to onset of 
analgesia is 4 minutes and duration of analgesia lasts for about 150 minutes. 
• Intranasal 
Fentanyl is administered with a metered dose device, with each spray delivering 
4.5µg fentanyl. Time to onset of analgesia is about 15 minutes.
• Transpulmonary
Inhalational administration of fentanyl produces rapid, effective drug delivery. A 
dose of 300µg of fentanyl administered via an oxygen driven nebulizer produces effective 
postoperative analgesia in 5 min and lasts for about 2 hours. 
• Neuraxial administration 
Epidural  and  intrathecal  administration  of  fentanyl  are  long 
established routes for intraoperative and postoperative analgesia. 
Epidural dose as a single bolus administration varies from 1-3µg/kg. 
Analgesia begins in 15 minutes, lasting for 2-4 hours. Epidural infusion rates 
range from 0.5-2.5µg/kg/h.  In addition,  fentanyl  has been used in patient 
controlled epidural analgesia (PCEA) in doses of 20-25µg with a lockout 
interval of 6-10min and background infusion in the rate 0.5-1µg/kg/h. 
The  minimum  intrathecal  bolus  requirement  for  postoperative 
analgesia  is  20µg while  a  dose of  10µg is  effective in obstetric patients. 
Onset  of  analgesia  is  usually  within  5-15min  and  duration  is  variable, 
ranging from 1 to 5 hours. Other modes of administration include continuous 
/ bolus administration via an intrathecal catheter. 
Clinical Applications 
• Premedication 
Fentanyl in doses of 50-100µg may be administered intramuscularly 
30-60 minutes prior to surgery. Oral transmucosal fentanyl citrate in doses 
between  15-20µg/kg,  administration  45  minutes  before  surgery  produces 
reliable  preoperative  sedation  and  facilitates  induction  of  anaesthesia  in 
children. 
• Adjunct to general anaesthesia. 
Fentanyl in doses of 1-2µg/kg given intravenously provides analgesia. It can be 
used as an adjuvant to blunt circulatory responses that occur during direct laryngoscopy 
for endotracheal intubation and sudden changes in the level of surgical stimulation. Large 
doses of fentanyl, 50-150µg/kg intravenously has been used as sole anesthetic agent 
especially in cardiothoracic procedures, principally because of its stable hemodynamic 
effects.
• Neruolept analgesia 
Innovar is a premixed combination, containing 2.5mg Droperidol and 
0.05mg  Fentanyl  in  each  ml  (50:1)  used  for  neurolept  analgesia  and 
anesthesia.
• Adjunct in Central neuraxial Block 
Fentanyl added to local anesthetic either intrathecally or epidurally, improves the 
quality of intraoperative analgesia and also provides good post operative  analgesia.
• Postoperative analgesia 
Fentanyl  administration  by  intravenous,  epidural,  intrathecal  and 
transdermal routes provide effective postoperative analgesia. Newer routes 
like  intranasal  and  inhalational  administration  are  being  evaluated  as 
minimally invasive means of post operative analgesia. 
Side Effects 
Commonly occurring side effects include dose dependent respiratory 
depression, nausea and vomiting, pruritus, urinary retention and bradycardia. 
These effects are reversed by administration of Naloxone intravenously. 
Intrathecal fentanyl 
Intrathecal  fentanyl  administration  is  an  established  route  for 
intraoperative and postoperative analgesia. 
Pharmacokinetics22
Fentanyl  has  the  same  baricity  as  cerebrospinal  fluid  at  room 
temperature and addition to hyperbaric lignocaine or bupivacaine makes the 
solution hyperbaric.  On injection into subarachnoid space,  fentanyl  mixes 
with CSF and attaches itself to spinal opioid receptors. Protein binding of 
drug in the CSF is negligible and the concentration of opioid in the CSF is 
thus free drug concentration. CSF dynamics do not provide any means of 
drug removal. Diffusion into the spinal cord and absorption into the blood 
flowing  through  spinal  cord  must  remove  all  the  fentanyl.  The  rate 
determining step of drug removal is likely to be the rate constant for fentanyl 
transfer from CSF to spinal cord and this rate constant is directly related to 
lipophilicity. Fentanyl can also migrate from the CSF into epidural vascular 
compartment via the dura. However, details of systemic pharmacokinetics of 
fentanyl are not known. Once in the CSF, fentanyl like other opioids, spreads 
rostrally. Because of the high affinity of fentanyl with binding sites in the 
lipid-rich spinal cord, only 10% of administered dose migrates to cervical 
region. 
Application 
Intrathecal  fentanyl  is  usually  combined with local  anaesthetics  for 
perioperative anaesthesia and analgesia, particularly in obstetrics. 
Fentanyl  administration  intrathecally  provides  more  intense  and 
complete analgesia at rest, at a lower dose requirement when compared to 
the epidural or intravenous routes. 
Modes of Administration and Dosage 
Fentanyl is administered intrathecally as single bolus injection or as 
repeated observer-administered, PCA boluses and continuous infusion via an 
intrathecal catheter. Effective postoperative analgesia can be achieved with 
bolus doses of 20µg. Infusions of 0.8µg/kg/h produces satisfactory analgesia 
in patients undergoing thoracotomy. 
Side Effects of Intrathecal fentanyl 
Side  effects  are  relatively  minor  with  intrathecal  fentanyl.  The 
incidence of clinically significant respiratory depression is relatively low, as 
intrathecal  administration of fentanyl  results in lower systemic absorption 
than epidural route and the intrathecal dose requirement is lower than the 
epidural  dose requirement.  A 30% incidence of urinary retention, varying 
incidence of pruritus and occasional episodes of nausea have been observed. 
PHYSIOLOGICAL AND ANATOMICAL CHANGES 
IN PREGNANCY
The hormone progesterone could be considered as the most important 
physiologic substance in pregnancy. The most important physiologic role of 
progesterone is its ability to relax smooth muscle. All other physiological 
changes stem from this pivotal function.
Cardiovascular system 
Blood Constituents
The blood volume increases by 35% in pregnancy and  is seen from 
first  trimester  and consists  of  increased  red cell  mass   by 20% and to  a 
greater  extent,  plasma   by  about  45%  with  consequent  reduction  in 
hemoglobin concentration despite a raised total hemoglobin content.
Cardiac output
 Cardiac output increases by 40-50%, heart rate increases by 15% and 
stroke volume is increased by 30%. The increase in cardiac output starts in 
the first trimester
Peripheral circulation
There  is  decreased  peripheral  resistance  and  no  change  in  venous 
pressure.  Blocking  autonomic  system may  result  in  dramatic  decrease  in 
arterial blood pressure suggesting a chronically active sympathetic tone.
Respiratory system
There is  edema of  upper  respiratory  tract  due to  mucosal  capillary 
engorgement.  Minute  ventilation  is  increased  by  50%.  Tidal  volume 
increases by 40% Respiratory rate increases by 15%. Total lung compliance 
reduces  by  30%  The  functional  residual  capacity  is  reduced  by  about 
15-20% at term. Residual volume is reduced by 20%.
Other systems 
Oxygen  consumption  increases.  Renal  blood  flow  and  glomerular 
filtration  rate  increase.  A  reduction  in  lower  esophageal  sphincter  tone 
occurs. Placental gastin increase gastric acidity. 
Epidural and subarachnoid spaces 
Engorgement  of  epidural  veins  is  seen  due  to  increased  intra 
abdominal  pressure  caused  by  gravid  uterus.  Gravid  uterus  ultimately 
reduces  both  epidural  and  sub  arachnoid  spaces.  The  nerve  fibers  have 
increased sensitivity to local anaesthetics during pregrancy (due to increased 
progesterone).
Supine hypotension syndrome
The  incidence  of  reduction  of  maternal  BP  associated  with  supine 
position is 10%. The reduction is associated with diaphoresis, nausea and 
vomiting, changes in cerebration is called supine hypotension syndrome.
On assuming supine position, gravid uterus totally compresses inferior 
vena  cava  resulting  in  pooling  of  venous  blood  and  increased  venous 
pressure in the lower extremities eventually decreasing the venous return to 
the  heart.  Hence  cardiac  output  decreases  and  ultimately  systemic  blood 
pressure falls. The increase in uterine venous pressure may affect the well 
being of the fetus through a resultant decrease in uterine blood flow. 
Compression  of  the  aorta  causes  arterial  hypotension  in  the  lower 
extremities  and  uterine  arteries  which  can  further  compromise  utero 
placental blood flow and result in fetal hypoxia. Since uterine blood flow is 
not auto regulated, blood flow to the uterus is directly proportional to the 
perfusion pressure, that is, the difference between uterine artery and venous 
pressure.  Hence  even  with  normal  upper  extremity  blood  pressure,  utero 
placental perfusion may decrease in supine position. 
Sympathetic blockade under spinal anaesthesia further decreases the 
venous return and the parturient’s ability to compensate by vasoconstriction. 
Thus  hypotension  is  much  more  common  and  severe  under  spinal 
anaesthesia. 
The incidence of supine hypotension can be minimised by nursing the 
patient in lateral position. Displacement of uterus can be achieved by giving 
a left lateral tilt of 150 to the operating table or elevation of right buttock 
10-15 cm with a wedge. 
 MATERIALS AND METHODS
This study was conducted between March 2006 and July 2006 at 
Government Raja Mirasudar Hospital,  Thanjavur Medical college, 
Thanjavur  after getting approval from the ethics committee. A total of 50 
patients who underwent elective caesarean section were taken up for the 
study. The age of the patients ranged from 20-37 years weighing 40-65 kg 
and height ranging from 140-167gms. All patients were thoroughly 
examined pre-operatively. Only patients belonging to ASA grade I and grade 
II were selected for the study. An initial preoperative counselling and 
reassurance to gain confidence of the patient was done. Informed consent 
was obtained and procedure was explained. 
Inj.Ranitidine  50mg  was  given  intravenously  as  premedication 
45minutes before surgery  and patients were randomized into  2 groups of 
25 each
Group A – patients received 1.5ml of 0.5% hyperbaric bupivacaine 
(7.5mg)
Group B – patients received 1ml of 0.5% Bupivacaine (5mg) with 0.5 
ml 
fentanyl (25 μg)
The final volume of the injected solution is 1.5ml on both groups.
In  the assessment room, vital  parameters like pulse rate,  blood pressure, 
respiratory rate and baseline investigations like hemoglobin, urine analysis 
for  albumin  and  sugar,  blood  sugar,  urea  and  creatinine  and  ECG were 
checked. Though examination of all the systems and airway assessment was 
done.
Visual Analog scale (VAS) was explained to the patient. The patients 
were shown a 10 cm long scale marked 0-10 on a blank paper and told that 
‘0’ represented ‘no pain’  and  10 represented worst possible pain. Patients 
were advised nil per oral 6 hours before the procedure. 
Procedure 
In the operating room, appropriate equipment for airway management and 
emergency drugs were kept ready. Patients were shifted to the operating room. The 
horizontal position of the operating table was checked and the patient was  placed on it. A 
Crawford  wedge was kept under the right buttock to give a lateral tilt to the uterus. The 
noninvasive blood pressure monitor, pulse oximeter and electro cardiogram leads were 
connected to the patient. Preoperative baseline systolic and diastolic blood pressure, pulse 
rate, respiratory rate and oxygen saturation was recorded. Patients were cannulated with 
18G intravenous cannula and preloaded with 1000ml of Ringers lactate.  The patient was 
placed in left lateral position. The skin over the back was prepared with antiseptic 
solution and draped with sterile towel. The L3- L4 interspaces was identified and 25G 
Quincke Babcock spinal needle was introduced in this space through midline approach. 
After confirming free flow of CSF, the prepared solution was injected. The patients were 
made to lie supine immediately after injection and left lateral tilt was provided by wedge 
under right buttock. The following parameters were observed: 
Sensory Block
Sensory block was assessed by loss of sensation to pinprick using 21G 
sterile needle bilaterally along the mid-clavicular line. This assessment was 
started immediately after turning the patient supine and continued every 15 
seconds till loss of sensation to pinprick at T 10 level was noticed. Onset of 
sensory block was taken as the time from intrathecal  injection to loss  of 
pinprick sensation at T 10  dermatome. This pin prick testing was continued 
till the peak block height was reached and the time was noted. Sensory block 
was checked every 15 minutes till sensory regression to L1 from the maximal 
level of sensory block . This interval is taken as the time to regression to L 1.
Motor block
Motor block was assessed bilaterally using modified  Bromage scale.
Modified Bromage scale  
0 - No block. Able to raise extended leg against gravity   
1 - unable to raise extended leg, just able to flex knees 
2 - unable to flex knees, but able to flex ankle
3 - Total block. Inability to flex ankle / move leg.
Assessment of motor block was started immediately after turning the 
patients supine. It was tested every 15 seconds till Bromage score of 1 was 
reached. Onset of motor block was taken as the time to achieve Bromage 
score  1  from the  time  of  injection.  The  degree  of  motor  block  after  30 
minutes of injection was noted and this was taken as the maximum degree of 
motor block. Thereafter, motor block was assessed every 15 minutes till it 
reached Bromage score or  0.  Duration of motor block was taken as time 
from subarachnoid injection to return of Bromage score to 0.  
Vital signs and side effects
 The systolic and diastolic blood pressure, pulse rate, respiratory rate 
and oxygen saturation were recorded every  minute for the first 10 minutes 
and thereafter every 5 minutes until the immediate post operative period.
Hypotension was defined as fall in systolic blood pressure >30% from 
baseline or  systolic  blood pressure  <90 mm Hg. This  was planned to be 
managed with intravenous ephedrine in increments of 6mg. Bradycardia was 
defined  as  heart  rate  <60/  min  and  was  planned  to  he  managed  with 
intravenous atropine 0.6 mg. Respiratory depression was said to be present if 
respiratory rate <8/ min and /or Spo2 <85%. This was planned to be managed 
with  mask ventilation or intubation and IPPV.
The occurrence of sedation was assessed using a bedside scale .
Sedation scale
0 – none Patient alert 
1 -  mild occasionally drowsy, easily aroused
2-  moderate Frequently drowsy, easily aroused
3-  Somnolent difficult to arouse 
Vomiting was planned to be managed with inj. ondansetron 8mg intravenously. 
Pruritus was planned to be managed with reassurance or inj. pheneramine maleate 22.5mg 
intravenously. Urinary retention was monitored post operatively and catheterization was 
planned in patients with retention>6 hours.  
Quality of surgical  anaesthesia
Surgical anaesthesia was graded ‘Excellent’ if there was no complaint 
of pain from the patient  at  any time during surgery,  ‘Good’ if  there was 
minimal pain or discomfort which was relieved by small dose of intravenous 
fentanyl 10μg and ‘poor’ if general anaesthesia had to be administered.
Assessment of pain in Post Anaesthesia care unit 
Patients were shifted to post anaesthesia care unit after completion of 
surgery. Vital signs were recorded every 15 minutes in the first hour after 
surgery, 30 minutes for the next  2 hours and thereafter every hour for the 
next  3  hours.  Sensory  and  motor  block  assessment  was  done  every  15 
minutes till recovery of pinprick sensation to L1 level and Bromage score 0 
respectively.  Patients  were  shifted  to  post  operative  ward  after  complete 
resolution of motor blockade and stabilization of blood pressure. 
Assessment of pain and duration of analgesia 
At the end of surgery, the degree of pain was assessed using Visual 
Analog scale (VAS). In the post anaesthesia care unit, pain assessment using 
VAS was done every 15 minutes till VAS score ≥ 4was reached. The VAS 
was  also  noted  whenever  the  patient  complained  of  pain.  Duration  of 
effective analgesia was defined as time interval between subarachnoid block 
and the time to reach VAS ≥ 4. Inj.  Diclofenac sodium 50mg was given 
intramuscularly as the rescue analgesic  when VAS reached ≥ 4.
Patients  were  monitored  for  24  hours  to  detect  side  effect  like 
respiratory depression, urinary retention, pruritus and nausea and vomiting.
Assessment of the fetus 
The APGAR scores at 1 minute and 5 minute intervals after delivery 
of the baby was noted. Significant depression was planned to he managed 
with proper resuscitative measures and by inj. naloxone 1-4μg/ kg .
OBSERVATION AND RESULTS
Of the 50 patients taken up for this study, 25 patients were randomly 
allocated 
to two groups.
Group A – Patients received 7.5mg of 0.5% hyperbaric bupivacaine (1.5 ml)
Group B – Patients received 5mg of 0.5%  hyperbaric bupivacaine (1ml) with 25μg 
       fentanyl (0.5ml).
Total volume was 1.5ml in both groups.
Age Distribution
The range of ages in group A was 20-37 years while in group B, it was 
20-35 years. The average age in both groups were similar.




The distribution of ages were also similar in both groups as shown by 
the following table and multiple bar diagram.   
                                                                               
Age in years Group A Group B
20 – 24 11 12
25 – 29 7 8
30 – 34 5 4
35 – 37 2 1
Weight distribution
The mean weight of the patients were comparable in both groups as 
shown by the table and bar diagram.




The mean height of the patients were comparable in both groups as shown by 
the table and bar diagram.





The mean time of  onset  of  sensory block at  T10 was  130.8  ± 22.3 
seconds in Group A with a range of 105-180 seconds and  138.6  ± 22.61 
seconds in Group B with a range of 105 – 180 seconds. They were similar 
and statistically not significant which was confirmed by unpaired Student’s t 
test(p > 0.1) as shown in the bar diagram.
Maximum level of sensory block
The range of maximal level of sensory block was T4 – T7 in Group A 
and in Group B, it was between T4 – T8.






Time to peak sensory block
In group A, the time taken to reach the maximum level was 259.2 ± 
26.88 seconds with a range of 210 – 300 seconds, whereas in Group B, it 
was 318 ± 33.26 seconds. This was statistically significant ( P < 0.05)
Time to regression to L1
The mean time to regression of sensory blockade to L1 was  122.4  ± 
10.31 minutes in Group A with a range of 105 – 135 minutes In Group B, it 
was  159.6  ± 14.28 minutes with a range of 135 – 195 minutes. This was 
statistically significant   ( P < 0.01).  
Motor Block
Onset of Grade I motor block
The  time taken to  achieve  Grade  1  motor  block was  159  ± 20.31 
seconds in group A with a range of 120 – 195 seconds. In group B, it was 
160.8 ± 22.3 seconds with a range of 135 – 210 seconds. This was found to 
be statistically insignificant 
( P > 0.1).
Maximum degree of motor block
The maximum degree motor block ranged between grade 3 and grade 




Group A Group B
GR  O 0 0
GR  1 0 0
GR  2 3 7
GR  3 22 18
Duration of motor block
The mean duration of motor block was 102±10.06 minutes in group A 
with a range of 75-120 minutes. In group B ,it was 70.8±11.06 minutes with 
a  range  of  60-90  minutes.  This  was  found  to  be  statistically  highly 
significant (P < 0.01)
Duration of effective analgesia
The mean duration of effective analgesia was 148.56 ± 13.13 minutes 
with  a  range  of  115 –  174 minutes  in  group A,  but  in  group B,  it  was 
200.32minutes with a range of 173 – 234 minutes.  This was statistically 
highly significant. (P < 0.01).
Quality of surgical anaesthesia
In  this  study,  the  quality  of  surgical  anesthesia  was  graded  as 
‘excellent’ in all but 3 patients in group A who complained of discomfort 
intraoperatively and required 10µg fentanyl intravenously.
Incidence of hypotension
In group A, 21 patients had hypotension whereas in group B, only 9 
patients had hypotension. The incidence is 84% with group A against 36% 
in group B. This was tested to be statistically significant  (P < 0.001).
Mean ephedrine requirements
The mean ephedrine required to  counter  hypotension  was  12mg in 
group A whereas it was 3.12mg in group B.
Side effects
The incidence of pruritus was 32% in Group B (8 patients) whereas it 
was  nil  with  group  A.  Pruritus  in  Group  B  was  mild  and  settled  with 
reassurance.
3 patients complained of nausea in Group A and none in Group B. 
This was attributed to the discomfort for which they received intreoperative 
supplemental  analgesia.  Bradycardia  and  respiratory  depression  did  not 
occur in any of the patients involved in the study.
Urinary  retention  was  seen  in  3  patients  in  Group  B,  they  were 
managed conservatively and one patient required catheterization.
Sedation of Grade 1 was seen with 7 patients in Group B.
Assessment of the fetus
All the babies showed 1 minute APGAR of 8 and above and 5 minute 
APGAR of 9 and above in both the groups. The difference was statistically 
insignificant.
REVIEW OF LITERATURE
Effects of Intrathecal Local Anaesthetic-Opioid Combination 
Akerman B, Arwestrom E, and Post C23 undertook a study in mice, to 
compare the antinociceptive effects of intrathecal  injection of mixtures of 
morphine with bupivacaine  or  lignocaine,  with the  effect  of  these agents 
when administered alone.  They observed an increase in  the intensity  and 
duration  of  antinociception  when  morphine  was  administered  with  local 
anaesthetics. They confirmed that morphine did not affect the motor block 
produced by local anaesthetics and confirmed the synergistic analgesic effect 
of the combination. 
Maves TJ and Gebhart GF24  conducted a study in rats to quantify the 
interaction  between  intrathecal  morphine  and lignocaine  using  models  of 
visceral  and  somatic  nociception.  They  demonstrated  antinociceptive 
synergy between intrathecal  morphine  and lignocaine during visceral  and 
somatic nociception at dosages that did not impair motor function.
Fraser  HM,  Chapman V and  Dickenson AH  25 tested  the  effect  of 
intrathecal lignocaine either alone or in combination with low dose morphine 
on the C, A δ and Aβ evoked responses of nociceptive neurons in the dorsal 
horn of rats. They observed marked potentiation of the inhibition of C-fibre 
responses  when  lignocaine  and  morphine  were  used  in  combination, 
compared to either agent used alone. 
Wang C, Chakrabarti MK and Whitman JG26 examined the effects of 
bupivacaine administered intrathecally on sympathetic efferent  and Aδ,  C 
fiber mediated afferent pathways in dogs and its interactions with intrathecal 
fentanyl. The concluded that intrathecal bupivacaine had no selectivity for 
the  afferent  and  efferent  pathways  and  that  intrathecal  fentanyl  acted 
synergistically to enhance the effect of bupivacaine on the afferent pathway 
without a measurable effect on sympathetic outflow. 
Intrathecal Fentanyl as Adjunct to Subarachnoid Local Anaesthetics
Hamber  EA and  Viscomi  CN1 analyzed the  efficacy  of  intrathecal 
lipophilic  opioids  as  adjuncts  to  spinal  anaesthesia  by reviewing medline 
literature from 1980 to the present. They reported benefits that included an 
enhancement  of  the  quality  of  spinal  anaesthesia  without   prologation  of 
motor  block,  the  need  for  smaller  doses  of  local  anaesthetic  and  less 
troublesome  side  effects  than  intrathecal  morphine.  They  suggested 
significant  roles  for  these  agents  as  adjuncts  for  spinal  anaesthesia  in 
obstetric and outpatient procedures.
        A study to evaluate the effect of intrathecal fentanyl on hyperbaric 
bupivacaine  induced  subarachnoid  block  was  done  by  Singh  H,  Yang  J, 
Thornton K and Giesecke AH on forty three male patients undergoing lower 
extremity or genitourinary surgery27.  They concluded that addition of 25μg 
fentanyl  to  13.5mg  of  hyperbaric  bupivacaine  prolonged  the  duration  of 
bupivacaine  induced  sensory  block  by  28%  and  reduced  the  analgesic 
requirement in the early postoperative period by 40%, without enhancing the 
onset of sensory and motor blocks or prolonging the duration of bupivacaine 
induced motor block.
Kuusniemi  KS,  Pihlajamaki  KK,  Pitkanen  MT,  Helenius  HY  and 
Kirvela OA28  evaluated the effect of 25μg fentanyl added intrathecally to 10 
mg, 7.5 mg and 5 mg of 0.5% bupivacaine in eighty patients undergoing 
urological procedures. They concluded that the addition of 25μg fentanyl to 
5 mg bupivacaine resulted in a short lasting motor block but the same level 
of sensory analgesia when compared to larger doses of bupivacaine with or 
without fentanyl.
The  effect  of  addition  of  fentanyl  to  bupivacaine  administered 
intrathecally for cesarean delivery was evaluated in 56 term parturients by 
Hunt CO et al29. They concluded that 67% of patients in the bupivacaine only 
group complained of intraoperative pain and required opioids. None of the 
patients  who  received  greater  than  or  equal  to  6.25µg  fentanyl  required 
intraoperative opioids and the duration of effective analgesia was prolonged 
by 120 minutes in the fentanyl group. 
Belzarena SD30 studied the clinical effects of subarachnoid fentanyl in 
120 women undergoing cesarean section under spinal anesthesia with 0.5% 
hyperbaric  bupivacaine  and concluded that  a  combination  of  bupivacaine 
with low dose (0.25µg/kg) fentanyl provided excellent surgical anaesthesia 
with short acting postoperative analgesia. 
Chu  CC et  al31.  studied  the  effect  of  0.5% hyperbaric  bupivacaine 
combined with  fentanyl  in  cesarean  section.  They concluded that  12.5µg 
fentanyl  increased  the  quality  of  surgical  analgesia  and  prolonged 
postoperative analgesia.
Shende G, Cooper M and Bowden MI32 concluded that adding 15 µg 
fentanyl to hyperbaric bupivacaine in spinal anesthesia markedly improves 
intraoperative anaesthesia for caesarean section.
Local Anaesthetic Sparing Effect of Intrathecal Fentanyl 
In  a  study  conducted  by  Ben-David  B,  Miller  G,  Gavriel  R  and 
Gurevitch A33, 32 women scheduled for cesarean delivery were randomized 
to receive spinal injection of either 10mg 0.5% isobaric bupivacaine or 5mg 
0.5%  isobaric  bupivacaine  with  25µg  fentanyl.  They  concluded  that 
bupivacaine  5mg  with  fentanyl  25µg  provided  good  surgical  anaesthesia 
with less  incidence  of   hypotension,  vasopressor  requirement  and nausea 
than 10mg bupivacaine. 
Ben-David B, Frankel, R, Arzumonov T, Marchevsky Y and Volpin 
G34 conducted a study on 20 patients aged > 70 years, undergoing surgical 
repair  of  hip  fracture.  Patients  were  randomized  to  receive  either  4mg 
bupivacaine with 20µg fentanyl or 10 mg bupivacaine alone intrathecally. 
They concluded that a ‘minidose’ of 4mg bupivacaine in combination with 
20µg  fentanyl  provided  good  surgical  anaesthesia,  while  causing  less 
hypotension and nearly eliminating the need for vasopressors compared to 
the 10mg bupivacaine group. 
Kang FC, Tsai YC, Chang PJ and Chen TY35 studied the effects of 5 
mg  hyperbaric  bupivacaine  with  25µg  fentanyl  against  8  mg  hyperbaric 
bupivacaine in spinal anaesthesia for caesarean section and concluded that 
small dose bupivacaine – fentanyl combination provided more hemodynamic 
stability when compared to bupivacaine alone.
Grant GJ, Susser,  Cascio M, Moses M and Zakowski MI36conducted a 
study on non labouring partiurients and concluded that 25µg fentanyl does 
not produce clinically important maternal hemodynamic changes.
Karmarez A, Kaya S, Turhanoglu S and Ozhyilmaz MA37 studied the 
effects of adding 25µg fentanyl to 4 mg plain  bupivacaine with 0.5%  plain 
bupivacaine  alone  in  spinal  anaesthesia  for  TURP  and  concluded  that 
hypotension was significantly more common in plain bupivacaine group.
Jain  K,  Grover  VK,  Mahajan  R  and  Batra  YK38 evaluated  the 
hemodynamic stability offered by varying doses of fentanyl with low dose 
bupivacaine for spinal anaesthesia in caesarean delivery and concluded that 
intrathecal  fentanyl  with  low  dose  bupivacaine  provides  good  surgical 
anaesthesia without compromising hemodynamics and neonatal outcome. 
Side Effect Profile of Intrathecal Fentanyl
Chaney MA39 in a retrospective review of literature on the side effects 
of intrathecal and epidural opioids reported pruritus, nausea and vomiting, 
urinary retention and respiratory depression as the four classic side effects, 
most of which were found to be dose related.
Varrassi G et al40. conducted a study to evaluate the ventilatory effects 
of  subarachnoid  fentanyl  50,  25  or  12.5µg.  They  concluded  that  50µg 
subarchnoid  fentanyl  caused  an  early  respiratory  depression  and 
recommended avoiding the dose for postoperative analgesia in the elderly. 
The other groups did not show occurrence of respiratory depression. Mild 
pruritus, sedation, nausea and vomiting were the other observed side effects 
in groups receiving 50 and 25µg fentanyl.
Siddik-Sayyid et al41. in a study on 48 parturients undergoing cesarean 
section concluded that supplementation of spinal bupivacaine anaesthesia for 
cesarean delivery with intrathecal fentanyl 12.5µg provided a better quality 
of anaesthesia and was associated with a decreased incidence of side effects 
when  compared  to  supplementation  with  the  same  dose  of  fentanyl 
intravenously.
Dahlgren  G  et  al42.  compared  the  effects  of  intrathecal  fentanyl, 
sufentanil or placebo when administered with 12.5mg of 0.5% hyperbaric 
bupivacaine for cesarean section. They observed that small doses of opioid 
added  to  bupivacaine  reduced  the  need  for  intraoperative  antiemetic 
medication and increased duration of  analgesia  in the early  postoperative 
period. Pruritus was a frequent and dose related side effect.
Herman  NL et  al43.   performed  a  study  to  establish  dose-response 
relationship  of  intrathecal  fentanyl  for  both  analgesia  and  ventilatory 
depression. They observed that ETCO2 displayed a dose-related increase at 
fentanyl doses > 15ug. They observed that even in the absence of overt signs 
and  symptoms  of  somnolence,  intrathecal  fentanyl  induced  a  change  in 
ventilation within the effective analgesic dose range. Pruritis also showed a 
dose-response relationship.
Manullung  TR,  Viscomi  CM  and  Pace  NL44 compared  intrathecal 
20µg fentanyl with intravenous ondanseteron 4 mg for prevention of nausea 
and  vomiting  during  cesarean  deliveries  under  spinal  anaesthesia.  They 
concluded  that  intrathecal  fentanyl  as  part  of  the  spinal  anaesthetic  for 
cesarean delivery was superior to intravenous ondanseteron for prevention of 
intraoperative nausea.
Neonatal outcome 
Corke BC, Datta S, Ostheimer GW, Weiss JB and Alper MH45 studied 
the effects of short period of maternal hypotension upon the neonate during 
initiation of spinal anaesthesia for cesarean section and concluded that short 
period of hypotension (< 2 minutes ) was not harmful to the neonate.
Kangas- Saarela T et al46 in a study on recovery of 16 infants born by 
spinal  anaesthesia  in  which  either  ephedrine  or  fluid  load  was  used  to 
prevent  maternal  hypotension  concluded  that  smaller  doses  of  ephedrine 
given  to  mother  to  prevent  maternal  hypotension  have  only  short  lived 
effects on neonate’s central nervous system.
Craig M, Palmer, James Mackintosh and Ronald C Cork et al47 studied 
the effects of intrathecal fentanyl on fetal heart rate changes and concluded 
that incidence of fetal heart rate changes was 6 to 12% and there was no 
changes in neonatal outcome.
DISCUSSION
The primary  aim of  this  study was  to  compare  the  efficacy of  the 
combination of 25µg fentanyl and 5 mg of hyperbaric bupivacaine  0.5% 
with  that  of  7.5mg  hyperbric  bupivacaine  alone  for  spinal  anesthesia  in 
LSCS regarding incidence of hypotension and mean ephedrine requirements 
apart from other usual  parameters.
Onset of sensory block
The mean time to onset at T10 was  130.8 seconds in Group A and 
138.6 seconds in Group B, Here, no statistically significant difference was 
noted.
This correlates with the study done by Singh H, Yang J, Thornton K and Giesecke 
AH27 who concluded that addition of intrathecal fentanyl 25µg to hyperbaric bupivacaine 
did not hasten the onset of sensory block.
Roussel JR and Heindel LS48 also concluded that addition of fentanyl 
25µg to 0.5% hyperbaric bupivacaine did not enhance the onset of sensory 
block.
Maximum level of sensory block
The median of the upper limit of sensory block was T5 in Group A and 
T6 in Group B, The addition of fentanyl to smaller dose of subarachnoid 
hyperbaric bupivacaine provided adequate level of sensory block.
This correlated with the study of Kuusniemi et al28 who demonstrated 
a sensory block height of greater than T7. They did not observe an increase in 
height  of  sensory  block  by  the  addition  of  25µg  fentanyl  to  intrathecal 
hyperbaric bupivacaine.
Time to peak sensory block
The time to peak sensory block was 259.2 seconds in Group A while 
it was  318 seconds in group B, a statistically significant observation. This 
may be probably attributed to the lower dose of bupivacaine in Group B.
Time to regression to L1
The mean time to  regression to  L1  was  122.4 minutes in  group A 
whereas  in  
Group  B,  it  was  159.6  minutes.  The  addition  of  fentanyl  25µg  to 
bupivacaine prolonged the time to regression to L1. This could be attributed 
to selective blockade of Aδ and C afferents which mediate the sensation of 
pin prick.
This  correlated  with  findings  of  Liu  S  et  al49who  concluded  that 
regression of pinprick, touch and cold was prolonged by addition of fentanyl 
to subarachnoid local anaesthetic.
Belzarena SD30 concluded that addition of fentanyl increased the time 
required  for  regression  to  T12 in  patients  receiving  fentanyl  –  local 
anaesthetic combination intrathecally for caesarean section.
Kuusniemi KS et al28 also showed a prolongation of sensory block with addition of 
fentanyl to bupivacaine intrathecally.
Ben David B, Solomon E, Levin H, Admoni H and Goldik Z50showed that the 
addition of 10µg fentanyl to small dose bupivacaine intensified and increased the duration 
of block.
Onset of Motor block
The time to achieve Grade I motor block on Bromage scale was 159 
seconds in group A and  160.8 seconds in group B which was statistically 
insignificant.
This observation correlated with the study done by Singh H, Yang JS, 
Thornton K and Giesecke AH27 who demonstrated that intrathecal fentanyl 
does not enhance the onset of bupivacaine induced motor block.
Maximum Grade of motor block
The median grade of motor block at 30 minute testing time measured 
using modified Bromage scale was Grade III in majority of patients among 
both  groups.  Patients  with  grade  II  block  were  also  comfortable  intra 
operatively.
Duration of Motor block
In our study, the mean duration of motor block was  102 minutes in 
group A and  70.8 minutes in group B which was significant.  Hence we 
conclude  that  addition  of  25µg  fentanyl  to  0.5% hyperbaric  bupivacaine 
intrathecally did not prolong the duration of motor block.
This correlated with the study of Singh H et  al27 who showed that 
addition  of  fentanyl  25µg  to  intrathecal  bupivacaine  did  not  prolong the 
duration of motor block.
The duration of  motor  block produced by bupivacaine intrethecally 
was  shown to be dose dependent. Our findings correlated with Liu et al49, 
who reported that each additional mg of bupivacaine was associated with an 
increase in the duration of motor block.
Duration of effective analgesia
The  mean  duration  of  effective  analgesia  was  148.56  minutes in 
Group  A  and  200.32  minutes in  group  B  which  was  highly  significant 
statistically.
This correlated with the study of Singh et al27who demonstrated that 
only  fewer  patients  receiving  fentanyl  25µg  with  0.5%  bupivacaine 
demanded pain relief in the early postoperative period when compared to 
patients receiving bupivacaine alone intrathecally. 
Fernandez Galinski et al51showed that 25µg fentanyl added to 12.5mg 
intrathecal bupivacaine significantly  decreased postoperative pain intensity.
Quality of surgical anaesthesia 
In  our  study,  3  patients  in  group  A  complained  of  discomfort 
intraoperatively  and  required  supplementation  with  intravenous  fentanyl 
10µg. The quality of surgical anaesthesia was excellent in all other patients.
Intrathecal  opiords  produce  analgesia  by  inhibition  of  synaptic 
transmission  in nociceptive afferent pathways. The improvement in quality 
of surgical anaesthesia by the addition of fentanyl to intrathecal bupivacaine 
was evident in our study.
This correlated with the study of Belzarena SD30 which showed that 
the  combination  of  bupivacaine  and  low dose  fentanyl  provide  excellent 
surgical  anaesthesia  (100%)  when  compared  to  bupivacaine  used  alone 
(87%) in spinal anaesthesia for caesarean section.
Our findings correlated with the study of Siddik – Sayyid et al41 who 
reported that spinal anesthesia with 0.5% bupivacaine and 12.5 µg fentanyl 
provided better quality of anaesthesia when compared to supplementation 
with same dose of fentanyl intravenously for cesarean section. 
Synergistic blockade of Aδ and C afferents by fentanyl allowed sub- 
therapetic  dose  of  bupivacaine  to  maintain  surgical  anaesthesia  during 
regression of spinal anaesthesia in our study.
Our results are consistent with experimental studies done by Tejwani 
GA et al52 and Akerman B et al who have shown that the combination of 
opioids and local anaesthetics are synergistic for somatic analgesia and that 
intrathecal opioids markedly enhanced analgesia from sub therapeutic dose 
of intrathecal local anaesthetics. 
Incidence of hypotension 
In our study, the incidence of hypotension was 84% in group A and 
36% in group B. This was statistically significant and could be attributed to 
the lower dose of bupivacaine used in the group. Our study confirmed the 
fact that the decrease in sympathetic efferent activity after spinal anesthesia 
with  bupivacaine  was  dose  related  and  that  intrathecal  fentanyl  caused 
neither by itself nor in combination with bupivacaine ,any further depression 
of efferent sympathetic activity 
This correlated with the study of Ben David et al34 who showed that a 
minidose  of  4mg  bupivacaine  and  20µg  fentanyl  given  intrathecally 
dramatically lowered the incidence of hypotension and nearly eliminated the 
need for vasopressors.
Another study by Ben David B et al33 confirms that 25µg fentanyl in 
combination  with  5  mg  isobaric  bupivacaine  caused  less  incidence  of 
hypotension (31%) when compared to 10mg isobaric bupivacaine (94%)in 
spinal anesthesia for caesearean section.
In the study done by Grant GJ et al36, it was confirmed that intrathecal 
administration of 25µg fentanyl did not produce clnically important maternal 
hemodynamic changes in non-laboring term parturients.
Kang FC et  al35,  in  their  study on spinal  anaesthesia  for  caesarean 
delivery revealed that the combination of small dose bupivacaine 5mg and 
fentanyl 25µg provided more stable hemodynamic status when compared to 
8mg hyberbaric bupivacaine used alone.
Mean ephedrine requirements
The mean ephedrine requirements were 12mg with group A and 3.12 
mg in group B. This is highly significant.
Ben David B et al33 confirms that the mean ephedrine requirements 
were 23.8mg with the combination of 5mg isobaric bupivacaine and 25µg 
fentanyl but it was 2.8mg with 10mg bupivacaine when used intrathecally 
for caesarean section. 
Kangas  Saarala  et  al46has  concluded  that  small  doses  of  ephedrine 
given to correct maternal hypotension  under spinal anaesthesia have only 
shortlived effect on the fetal central nervous system.
Side effects
Pruritus occurred in 8 patients in group B, its incidence being 32% .It 
was mild and occurred most commonly in the face .
Our study correlated with the view of Hamber EA and Viscomi CM 
that pruritus being a common complication with intrathecal fentanyl.
Kuusniemi KS et al28 reported pruritus as the most common adverse 
effect occurring in 22.5 % of the patients receiving intrathecal fentanyl with 
bupivacaine which correlated with our study.
In  our  study,  3  patients  in  group  A  complained  of  nausea 
intraoperatively. This could be attributed to the discomfort these patients felt 
intraoperatively for which supplementation of analgesia was given. 
The occurrence of excellent surgical anaesthesia in patients receiving 
fentanyl could be the cause for absence of nausea in group B. This correlates 
with the study  conducted by Manullang TR et al44 which concludes that 
intrathecal fentanyl as a part of spinal anesthetic for caesarean delivery was 
superior to intravenous ondansetron for preventing intraoperative nausea.
Sedation of grade I was seen in 7 patients in group B. Patients were 
easily arousable and this could be attributed to the addition of fentanyl.
Uninary retention upto 6 hours was noticed in 3 patients in group B. It 
is thought to be caused by an increase in the urethral sphincter tone and a 
decrease in detrusor tone. 2 patients were managed conservatively  and they 
passed urine. One patient required catheterisation.
A single dose of intrathecal fentanyl does not migrate to the medullary 
respiratory center in sufficient concentration to cause respiratory depression. 
Consistent with this observation, respiratory depression did not occur in our 
study
Bradycardia  did not occur in either of the groups in our study.
Assessment of the fetus 
The APGAR scores at 1 minute and 5 minutes were comparable in 
both  the  groups  and  was  statistically  insignificant.  This  proves  that 
intrathecal fentanyl 25µg as an adjuvant to hyperbaric bupivacaine does not 
adversely affect the neonatal outcome.         
 
SUMMARY
This study was designed to compare the efficacy of the combination of 
25µg fentanyl  and 5mg hyperbaric  bupivacaine  0.5% with that  of  7.5mg 
hyperbaric  bupivacaine  0.5%  alone  intrathecally  for  lower  segment 
caesarean section. The observations are: 
1. The incidence of hypotension was significantly reduced by fentanyl- 
low dose bupivacaine combination.
2. The low dose bupivacaine–fentanyl combination significantly reduced 
the  ephedrine requirements to treat hypotension.
3. Intrathecal fentanyl improved the quality of surgical anaesthesia. 
4. The addition of fentanyl significantly prolonged the time to sensory 
regression to L1 
5. The addition of fentanyl allowed low dose bupivacaine to prolong the 
duration  of  effective  post  operative  analgesia  with  rapid  motor 
recovery.
6. The addition of fentanyl intrathecally had no effect on the onset of 
bupivacaine induced sensory and motor block .
7. The incidence of side effects was limited  to mild pruritus and grade I 
sedation in the fentanyl added group.
8. Intrathecal fentanyl does not adversely affect the neonatal outcome 
CONCLUSION
This  study confirms that  the combination of  intrathecal  fentanyl  25µg 
with 5mg hyperbaric bupivacaine 0.5% reduces the incidence of hypotension 
and ephedrine requirements, produces excellent surgical anesthesia, prolongs 
the duration of effective analgesia with rapid motor recovery and minimal 
side effects when compared to 7.5mg hyperbaric bupivacaine 0.5% in lower 
segment  caesarean  section  without  significant  effects  on  the  neonatal 
outcome.
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